Replacing acid α-glucosidase in Pompe disease: recombinant and transgenic enzymes are equipotent, but neither completely clears glycogen from type II muscle fibersNina Raben, Paul H. Plötz, Kunio Nagashima et al.|Molecular Therapy|2004Cited by 138
IFN-γ and Fas/FasL are required for the antitumor and antiangiogenic effects of IL-12/pulse IL-2 therapyJon M. Wigginton, Robert H. Wiltrout, Timothy Back et al.|Journal of Clinical Investigation|2001Cited by 126
IFN-γ and Fas/FasL are required for the antitumor and antiangiogenic effects of IL-12/pulse IL-2 therapyJon M. Wigginton, Robert H. Wiltrout, Eilene Gruys et al.|Journal of Clinical Investigation|2001Cited by 109
Development of a galvanic nitrogen dioxide sensor with silver ion conducting polymer sheet.Nobuo NAKANO, Kunio Nagashima, Takeo Hara et al.|BUNSEKI KAGAKU|1993Cited by 0